New clinical risk management tools are needed to prevent COVID-19 deaths

A new study exposes the dire need for new clinical risk management tools to help hospital healthcare workers prevent the deaths and intensive care admissions of Black, Asian and minority ethnic COVID-19 patients with pneumonia, say researchers. The call for healthcare policy change comes after a new study led by BHP founder-member the University of … Continue reading “New clinical risk management tools are needed to prevent COVID-19 deaths”

CPAP reduces need for invasive ventilation – West Midlands trial reports

Results from the RECOVERY-RS trial, which assessed different ways to provide oxygen support for patients in hospital with COVID-19, have found that continuous positive airway pressure (CPAP) reduced the need for invasive mechanical ventilation. BHP founder-member University Hospitals Birmingham recruited more than 400 patients to the trial – more than one third of the overall … Continue reading “CPAP reduces need for invasive ventilation – West Midlands trial reports”

Licensed drug could reduce SARS-CoV-2 infection by up to 70%

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70%, reveals a laboratory study by an international collaboration of researchers. The research team, led by the University of Birmingham and Keele University in the UK and the San … Continue reading “Licensed drug could reduce SARS-CoV-2 infection by up to 70%”

New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease

A new £850k collaboration between Birmingham Health Partners (BHP) and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease (IBD) by investigating promising biomarkers and inflammatory mechanisms in the search for new treatment targets. IBD affects around 250,000 people in the UK in the form of … Continue reading “New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease”

World-first trial to assess ‘life-extending’ cannabis-based drug for thousands with aggressive brain tumours

BHP founder member the University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours. The new phase II trial, to be funded by The Brain Tumour Charity, is to launch at 15 NHS hospitals and follows promising results from a … Continue reading “World-first trial to assess ‘life-extending’ cannabis-based drug for thousands with aggressive brain tumours”